97
Participants
Start Date
May 5, 2020
Primary Completion Date
August 12, 2020
Study Completion Date
August 12, 2020
Tociliuzumab
Participants will receive IV TCZ.
SUNY Downstate Medical Center., Brooklyn
Jamaica Hospital Medical Center, Jamaica
Allegheny Health Network (Pittsburg PA), Pittsburgh
Lehigh Valley Health Network, Allentown
Temple University Hospital, Philadelphia
Medstar Georgetown University Hospital, Washington D.C.
University of Maryland, Baltimore
Wake Forest University Health Sciences, Winston-Salem
Medical University of South Carolina, Charleston
Mayo Clinic, Jacksonville
Mercy St. Vincent Medical Center, Toledo
University Hospitals Cleveland Medical Center, Cleveland
Advocate Lutheran General Hospital, Park Ridge
Advocate Christ Medical Center, Oak Lawn
Houston Methodist Hospital, Houston
Michael E. DeBakey VA Medical Center, Houston
Houston Methodist Sugar Land Hospital, Sugar Land
Mayo Clinic - Arizona, Phoenix
Renown Institute for Heart & Vascular Health, Reno
LAC + USC Medical Center, Los Angeles
USC Keck Medical Center of USC, Los Angeles
St. Jude Medical Center, Fullerton
Norwalk Hospital, Norwalk
St Joseph's Regional Medical Center, Wayne
Hoffmann-La Roche
INDUSTRY